Tatsuya Kobayashi

Assistant Professor

Tokyo Women's Medical University

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Tatsuya Kobayashi is an Assistant Professor at Tokyo Women's Medical University in Japan. His research primarily focuses on immunotherapy and treatment strategies for various types of cancer, including hepatocellular carcinoma and glioblastoma. Recent publications highlight his work on dendritic cell activation, PD-L1 expression quantification, and the efficacy of novel therapeutic options in treating drug-resistant glioblastoma.

Articles (9)

Year:

2025

Year:

2025

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Homan Kang

Assistant Professor

Massachusetts General Hospital

UNITED STATES

View details

Koichi Ichimura

Specially Appointed Professor

Juntendo University

JAPAN

View details

Dan G. Duda

Associate Professor

UNITED STATES

View details

Daisuke Kawauchi

University of California, San Diego

UNITED STATES

View details

Hideki Yamaguchi

Chief

JAPAN

View details

Hak Soo Choi

Associate Professor

Harvard Medical School

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tatsuya Kobayashi

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Combination CXCR4 and PD-1 Blockade Enhances Intratumoral Dendritic Cell Activation and Immune Responses Against Hepatocellular Carcinoma

Fluorescence Lifetime Imaging Enables In Vivo Quantification of PD-L1 Expression and Intertumoral Heterogeneity

Therapeutic Options for Recurrent Glioblastoma—Efficacy of Talaporfin Sodium Mediated Photodynamic Therapy

Therapeutic Options for Recurrent Glioblastoma-Efficacy of Talaporfin Sodium Mediated Photodynamic Therapy

Lomustine and nimustine exert efficient antitumor effects against glioblastoma models with acquired temozolomide resistance

The ALK inhibitors, alectinib and ceritinib, induce ALK-independent and STAT3-dependent glioblastoma cell death

Enhanced Malignant Phenotypes of Glioblastoma Cells Surviving NPe6-Mediated Photodynamic Therapy are Regulated via ERK1/2 Activation

Enhanced Malignant Phenotypes of Glioblastoma Cells Surviving NPe6-Mediated Photodynamic Therapy are Regulated via ERK1/2 Activation

The emerging role of intraoperative flow cytometry in intracranial tumor surgery

Collaborators (6)

Homan Kang

Koichi Ichimura

Dan G. Duda

Daisuke Kawauchi

Hideki Yamaguchi

Hak Soo Choi

Make your next move.